Omenn Syndrome

What is Omenn Syndrome?

Omenn Syndrome is a rare genetic disorder that affects the immune system from birth. It is a type of severe combined immunodeficiency, meaning the body cannot fight off infections properly. Unlike typical immune deficiency disorders, Omenn Syndrome causes an unusual pattern where certain white blood cells multiply in large numbers but do not work correctly.

This condition appears in newborns and infants, usually within the first few months of life. The immune cells that should protect the body instead attack the skin and organs. This creates inflammation throughout the body. Without early diagnosis and treatment, this condition can be life threatening.

Omenn Syndrome is caused by mutations in genes that control immune cell development. These mutations are inherited from both parents. The condition is extremely rare, affecting fewer than 1 in 100,000 births. Early detection through blood tests can help doctors start treatment quickly.

Symptoms

  • Severe red, scaly rash covering most of the body, known as erythroderma
  • Chronic diarrhea and failure to gain weight properly
  • Enlarged lymph nodes throughout the body
  • Enlarged liver and spleen
  • Sparse or absent hair and eyebrows
  • Recurring infections including pneumonia and skin infections
  • Fever without clear infection source
  • Irritability and poor feeding in infants

Most infants with Omenn Syndrome show symptoms within the first 3 months of life. The skin rash is often one of the first signs parents notice. Unlike some immune disorders, this condition always causes noticeable symptoms early in life.

Pay with HSA/FSA

Concerned about Omenn Syndrome? Check your levels.

Screen for 1,200+ health conditions

Screen for 1,200+ health conditions
Hassle-free all-in-one body check
Testing 2 times a year and on-demand
Health insights from licensed doctors
Clear next steps for instant action
Track progress & monitor trends
Results explained in plain English
No insurance, no hidden fees

Causes and risk factors

Omenn Syndrome is caused by genetic mutations that affect how immune cells develop. The most common mutations occur in genes called RAG1 and RAG2, which help build functioning T-cells and B-cells. These immune cells are supposed to protect the body from infections. When the genes are damaged, the immune cells form incorrectly. They multiply in large numbers but cannot perform their protective job. Instead, they attack the body's own tissues.

This condition follows an autosomal recessive pattern, meaning a child must inherit one mutated gene from each parent to develop the syndrome. Parents who carry one copy of the mutation usually have no symptoms themselves. Families with a history of severe immune disorders or unexplained infant deaths may have higher risk. There are no lifestyle or environmental factors that cause this genetic condition.

How it's diagnosed

Doctors diagnose Omenn Syndrome through a combination of clinical symptoms and blood tests. Blood work typically shows very high levels of eosinophils, a type of white blood cell that fights parasites and allergies. Lymphocyte counts may appear normal or even elevated, but these cells do not function properly. The lymphocytes present are oligoclonal, meaning they come from only a few cell lines instead of a diverse population. Blood tests also show very high levels of IgE, an antibody associated with allergic reactions.

Rite Aid offers blood testing that measures eosinophils and lymphocytes, which are key markers for detecting this condition. Genetic testing confirms the diagnosis by identifying specific mutations in immune system genes. A bone marrow examination may also be performed. Early diagnosis is critical because prompt treatment can save lives.

Treatment options

  • Stem cell transplantation or bone marrow transplant, which is the only cure for this condition
  • Intravenous immunoglobulin, or IVIG, to provide temporary immune support
  • Antibiotics and antifungal medications to prevent and treat infections
  • Isolation precautions to reduce infection exposure until transplant
  • Nutritional support including specialized formulas for infants with chronic diarrhea
  • Skin care treatments to manage severe rash and prevent skin infections
  • Corticosteroid medications to reduce inflammation in some cases

Treatment requires care from specialists in pediatric immunology and bone marrow transplantation. Infants diagnosed with Omenn Syndrome need immediate referral to a specialized medical center. The earlier a bone marrow transplant is performed, the better the outcome. Talk to a pediatric immunologist right away if your infant shows symptoms.

Concerned about Omenn Syndrome? Get tested at Rite Aid.

  • Simple blood draw at your nearest lab
  • Results in days, not weeks
  • Share results with your doctor
Get tested

Frequently asked questions

Omenn Syndrome is a rare genetic disorder that affects the immune system from birth. It is a type of severe combined immunodeficiency where certain immune cells multiply but do not work correctly. These abnormal cells attack the body's own tissues instead of protecting against infections. The condition causes severe skin rash, infections, and inflammation in multiple organs.

The first signs usually appear within the first 3 months of life. Most infants develop a severe red, scaly rash that covers much of the body. Other early signs include chronic diarrhea, failure to gain weight, and recurring infections. Parents may also notice enlarged lymph nodes, sparse hair, and persistent fever.

Diagnosis involves blood tests that show very high eosinophil counts and abnormal lymphocyte patterns. Blood work also reveals elevated IgE levels. Genetic testing confirms the diagnosis by identifying specific mutations in immune system genes. Early diagnosis through blood testing is critical for starting life-saving treatment quickly.

Yes, Omenn Syndrome can be cured with a stem cell or bone marrow transplant. This procedure replaces the faulty immune system with healthy cells from a donor. Without transplant, the condition is fatal. The earlier the transplant is performed after diagnosis, the better the long-term outcomes and survival rates.

Yes, Omenn Syndrome is inherited in an autosomal recessive pattern. This means a child must receive one mutated gene from each parent to develop the condition. Parents who each carry one copy of the mutation typically have no symptoms themselves. Genetic counseling can help families understand their risk for future pregnancies.

Key blood tests include eosinophil and lymphocyte counts. Infants with Omenn Syndrome show very high eosinophil levels and abnormal lymphocyte patterns. Blood tests also measure immunoglobulin levels, particularly IgE, which is typically very elevated. These blood markers help doctors identify the condition quickly so treatment can begin.

Omenn Syndrome is extremely rare, affecting fewer than 1 in 100,000 births. Because it is so uncommon, many pediatricians may never see a case during their career. However, newborn screening programs in some regions are helping identify cases earlier. Families with a history of severe immune disorders may have higher risk.

The rash is caused by abnormal immune cells attacking the skin tissue. These faulty T-cells infiltrate the skin and trigger severe inflammation. The result is erythroderma, a condition where most of the body becomes red, scaly, and inflamed. This rash is often one of the most visible and early symptoms of the syndrome.

Lifestyle changes alone cannot treat Omenn Syndrome, as it requires medical intervention. However, protective measures are important before transplant. Keeping the infant isolated from sick people reduces infection risk. Using gentle skin care products helps manage the rash. Specialized nutrition support addresses feeding difficulties and chronic diarrhea.

Without treatment, Omenn Syndrome is fatal, usually within the first year of life. The combination of severe infections, organ damage from inflammation, and malnutrition overwhelms the body. Early diagnosis and prompt bone marrow transplant are essential. With successful transplant, many children can survive and develop normal immune function over time.

Related medications